首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.
【24h】

Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

机译:大环内酯类和氟喹诺酮类抗生素对室性心律失常和心脏骤停风险的影响:一项在意大利进行的病例对照,病例交叉和病例时间对照设计的观察性研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To compare the effect of macrolide and fluoroquinolone antibacterials on the onset of ventricular arrhythmia and cardiac arrest using three different observational designs. METHODS: A population-based case-control study was performed by linking automated databases from the Varese Province of Italy. Cases were all subjects who experienced ventricular arrhythmia or cardiac arrest from July 1998 to December 2003. For each case, up to ten controls were randomly selected after matching for sex, age, practitioner and date of arrhythmia onset. The use of macrolides and fluoroquinolones during two time windows denoted as recent and referent intervals was ascertained. Odds ratios were estimated using case-control, case-crossover and case-time-control approaches. RESULTS: 1275 cases and 9189 controls met the inclusion criteria. Adjusted odds ratios (and corresponding 95% CIs) associated with recent exposure to macrolides were 2.13 (1.34, 3.39), 1.70 (0.88, 3.26) and 1.62 (0.78, 3.34) by using case-control, case-crossover and case-time-control designs, respectively. The corresponding estimates for fluoroquinolones were 3.58 (2.51, 5.12), 1.98 (1.19, 3.29) and 1.59 (0.88, 2.87), respectively. CONCLUSIONS: Three observational study designs each using entirely different sets of controls consistently showed that recent use of macrolide and fluoroquinolone antibacterials may be associated with increased risk of ventricular arrhythmia and cardiac arrest.
机译:目的:采用三种不同的观察设计,比较大环内酯类和氟喹诺酮类抗生素对心律失常和心脏骤停发作的影响。方法:通过链接意大利瓦雷泽省的自动化数据库进行了基于人群的病例对照研究。病例均为1998年7月至2003年12月经历室性心律不齐或心脏骤停的受试者。对于每个病例,在匹配性别,年龄,医生和心律失常发生日期后,随机选择多达十个对照。确定在两个时间窗内使用大环内酯类和氟喹诺酮类药物表示为最近间隔和参考间隔。使用案例控制,案例交叉和案例时间控制方法估算赔率。结果:1275例和9189例对照符合纳入标准。通过病例对照,病例交叉和病例时间分析,与近期接触大环内酯类药物相关的调整后的优势比(和相应的95%CI)为2.13(1.34,3.39),1.70(0.88,3.26)和1.62(0.78,3.34)控制设计。氟喹诺酮类药物的相应估计分别为3.58(2.51、5.12),1.98(1.19、3.29)和1.59(0.88、2.87)。结论:三项观察性研究设计均使用完全不同的对照组,这些研究一致表明,最近使用大环内酯类和氟喹诺酮类抗菌药物可能与室性心律不齐和心脏骤停的风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号